Degree of myopia connected to birth weight and ROP severity

Article

Retinopathy of prematurity (ROP) and birth weight are strongly linked to degree of myopia in children.

Retinopathy of prematurity (ROP) and birth weight are strongly linked to degree of myopia in children, according to a paper featured in the Journal of Optometry.

Dr Bariah Mohd-Ali et al., Optometry Department, Faculty of Allied Health Sciences, Universiti Kebangsaan, Kuala Lumpur, Malaysia, conducted a retrospective review on 102 clinical records of preterm babies born between the years 2000 and 2008.

The information gathered included gender, race, age at birth, current age, birth weight, current weight, fundus examination records, visual acuity (VA), refraction and strabismus. Follow-up data from 1 to 6 years of age was also used in the investigation. Average birth weight was 1.37 ± 0.36 kg and average gestational age was 30.83 ± 2.42 weeks.

It was found that 38 of the 102 children had ROP and 64 didn't have ROP. Children with ROP developed myopia and children without ROP commonly developed hyperopia. Also, a significant improvement in VA was recorded as the children aged.

The study strongly suggests the consideration of birth weight and presence of ROP in children during the screening of vision and refractive error.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
© 2025 MJH Life Sciences

All rights reserved.